SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION
Recruiting now
Conditions studied: Immunodeficiency, Autoimmune Diseases, Autoinflammatory Syndrome, Allergy, Dysregulated Host Response
In brief
The aim of the SAID study is to create a national resource in Sweden to enable comprehensive immunological analyses of an extremely complex and clinically challenging group of individuals with variable forms of immune system dysregulation. We hope to establish a biobank of primarily blood and fecal samples from children and adults, with confirmed or suspected immune dysregulation, as well as age- and sex- matched healthy controls, for comparisons of immune cell/mediator alongside various clinical presentations of these immunological diseases as well as microbiome samples as possible a possible modifier of clinical presentations. The project will also include the establishment of a national database with deep immunological data, treatment and clinical outcomes for these patients, accessible to participating researchers and clinicians.
Key facts
- Study ID
- NCT06248957
- Run by
- Karolinska Institutet
- People needed
- 500
- Starts
- 2024-01-01
- Expected to finish
- 2031-12-31
- Last updated by the study team
- 2024-02-08
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients of all ages seeking care or being referred for suspected immune dysregulation or with a known immune-mediated disease and failing to respond to standard therapy
You may not qualify if…
- Healthy control individuals will be excluded on the basis of having a diagnosis of an immune mediated disorder, immunomodulatory treatment or current infection or cancer.
Where it is running
- Karolinska Institutet — Stockholm, Sweden (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.